Supera, IDev Technologies' biliary and peripheral stent, has shown "excellent durability" in a trial.
The Leipzig Registry enrolled 107 patients who were treated for peripheral arterial disease of the superficial femoral artery (SFA). Around...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?